ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02820324
Recruitment Status : Completed
First Posted : June 30, 2016
Last Update Posted : July 11, 2017
Sponsor:
Information provided by (Responsible Party):
Trevena Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : January 2017
  Certification/Extension First Submitted : July 7, 2017